title: Management of pulmonary hypertension.
abstract: Pulmonary arterial hypertension (PAH) is a potentially lethal disease mainly affecting young females. Although the precise mechanism of PAH is unknown, the past decade has seen the advent of many new classes of drugs with improvement in the overall prognosis of the disease. Unfortunately the therapeutic options for PAH in South Africa are severely limited. The Working Group on PAH is a joint effort by the South African Heart Association and the South African Thoracic Society tasked with improving the recognition and management of patients with PAH. This article provides a brief summary of the disease and the recommendations of the first meeting of the Working Group.
authors.forename: M R
authors.initials: MR
authors.lastname: Essop
authors.forename: N
authors.initials: N
authors.lastname: Galie
authors.forename: D B
authors.initials: DB
authors.lastname: Badesch
authors.forename: U
authors.initials: U
authors.lastname: Lalloo
authors.forename: A G
authors.initials: AG
authors.lastname: Mahomed
authors.forename: D P
authors.initials: DP
authors.lastname: Naidoo
authors.forename: M
authors.initials: M
authors.lastname: Ntsekhe
authors.forename: P G
authors.initials: PG
authors.lastname: Williams
mesh_terms: D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D011379:Prognosis; D012955:Societies, Medical; D013019:South Africa / Q000453:epidemiology